Delivery Order SPE2DB22D1106-SPE2DB23FEQG8
Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $57K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $25,931.08 to Amerisourcebergen Drug Corporation for 4561919850 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 24, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,838 to Amerisourcebergen Drug Corporation for 4561772937 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 11, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,640.84 to Amerisourcebergen Drug Corporation for 4561772767 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,199.46 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ABRAXANE 100 MG vials. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds several other indefinite delivery contracts with DLA and the Department of Justice Federal Bureau of Investigation Headquarters Division to supply pharmaceuticals and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,013.11 to Amerisourcebergen Drug Corporation for 4561772065 units of the cancer drug Abraxane in 100mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 11, 2023 under the terms of the order. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, indicating this contract supports...
- The Defense Logistics Agency awarded a $8,853.94 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abraxane 100 mg vials, with an ultimate completion date of August 27, 2025. This contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency issued a $4,715.48 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Abraxane 100 mg vials with an ultimate completion date of March 24, 2026. The order is priced on a firm fixed-price basis with no set-aside. Place of performance is Conshohocken, Pennsylvania. The order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at up to $999,999,999 through...
- The Defense Logistics Agency issued a $8,437.60 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Abraxane 100 mg vials, with an ultimate completion date of March 11, 2026. The order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which provides a comprehensive global pharmaceutical support vehicle enabling delivery of a vast range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $17,384.11 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication used in cancer treatment. This competitively awarded, firm fixed-price contract was issued on June 24, 2025, with an ultimate completion date of June 25, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under...